V. Prabhu

发表

Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection

E. Dubberke, E. Elbasha, S. Marcella, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

Matthew Biggerstaff, Lynnette Brammer, Carrie Reed, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update.

Angela B. Hutchinson, S. Sansom, V. Prabhu, 2009, AIDS.

An economic reappraisal of the Melamchi water supply project - Kathmandu, Nepal

Dale Whittington, Donald T. Lauria, Joseph Cook, 2004 .

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK

V. Prabhu, S. Merchant, E. Sarpong, 2017, Journal of medical economics.

Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data

W. Greiner, M. Reuschenbach, V. Prabhu, 2022, Journal of health economics and outcomes research.

Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy.

R. de Wit, P. Grivas, S. Keefe, 2019, European urology oncology.

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States

E. Elbasha, V. Prabhu, S. Kothari, 2021, Human vaccines & immunotherapeutics.

Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer.

Jason D. Wright, D. Hershman, A. Melamed, 2022, Gynecologic oncology.

Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data

L. Niccolai, V. Prabhu, S. Kothari, 2021, Open forum infectious diseases.

Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden.

R. de Wit, R. Perini, V. Prabhu, 2020, European urology oncology.

Adjuvant and first line chemotherapy use for endometrial cancer

Jason D. Wright, V. Prabhu, Yongmei Huang, 2022, Gynecologic oncology reports.

Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials

E. Dubberke, A. Basu, S. Marcella, 2018, Open forum infectious diseases.

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States

S. Sen, R. Borse, J. Solomkin, 2017, Antimicrobial Resistance & Infection Control.

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States

S. Corman, S. Kelkar, L. Duska, 2022, Gynecologic oncology reports.

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

T. Cheung, V. Prabhu, Sally Shuk-Yee Cheng, 2021, Cost Effectiveness and Resource Allocation.

HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States

E. Myers, V. Prabhu, N. Bansal, 2020, BMC Public Health.

Cost-Effectiveness of Newborn Circumcision in Reducing Lifetime HIV Risk among U.S. Males

Allan W. Taylor, Arielle Lasry, R. Shrestha, 2010, PloS one.

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

E. Dubberke, V. Prabhu, T. Mast, 2016, BMC Infectious Diseases.

S. Sen, R. Borse, J. Solomkin, 2017, Antimicrobial Resistance & Infection Control.

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

S. Sen, R. Borse, A. Basu, 2017, BMC Infectious Diseases.

Income pooling and demand aggregation in low-income households in Navi Mumbai, India: evidence from willingness to pay, risky choices and anthropometrics

V. Prabhu, 2007 .

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

M. Davies, B. Charbonnel, S. Engel, 2013, Diabetologia.

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States.

S. Corman, S. Kelkar, L. Duska, 2022, Gynecologic oncology.

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States

Dongmu Zhang, S. Marcella, V. Prabhu, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

S. Corman, E. Myers, V. Prabhu, 2021, Frontiers in Public Health.

Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings

B. Branson, P. Kerndt, R. Bolan, 2010, PLoS medicine.

Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis

M. Golden, J. Brooks, D. Rimland, 2011, PloS one.

Burden of CIN2+ diagnoses and conizations in women aged 18–45 years—a retrospective secondary data analysis of German statutory health insurance claims data

W. Greiner, M. Reuschenbach, V. Prabhu, 2022, Archives of Gynecology and Obstetrics.

Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States

M. Einstein, E. Myers, V. Prabhu, 2021, Current medical research and opinion.

S. Pignata, I. Ray-Coquard, N. Colombo, 2021, Journal of Clinical Oncology.

S. Pignata, I. Ray-Coquard, N. Colombo, 2023, European Journal of Cancer.

Household demand for preventive HIV/AIDS vaccines in Thailand: do husbands' and wives' preferences differ?

Christine Poulos, Dale Whittington, C. Poulos, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection

E. Dubberke, S. Marcella, O. Cornely, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tests of Intrahousehold Resource Allocation Using a CV Framework: A Comparison of Husbands’ and Wives’ Separate and Joint WTP in the Slums of Navi-Mumbai, India

V. Prabhu, 2010 .

Clinical and economic impact of school-based nonavalent human papillomavirus vaccination in females in Malaysia.

V. Prabhu, A. Pavelyev, Kunal Saxena, 2023, Singapore medical journal.

Information needs during cancer care: qualitative research with advanced cervical cancer patients in Brazil, China, Germany, and the United States

R. Salani, V. Prabhu, E. Szamreta, 2022, Gynecologic Oncology Reports.